Evaluation of cardiac findings in mucopolysaccharidosis

被引:2
作者
Dehghan, Bahar [1 ]
Rostampour, Noushin [2 ]
Sedighi, Mohsen [3 ]
Saryazdi, Mohammad Hosseini [4 ]
Rizi, Mohammad Jokar [4 ]
Mostofizadeh, Neda [2 ]
Hashemipour, Mahin [2 ]
Khoshhali, Mehri [5 ]
机构
[1] Isfahan Univ Med Sci, Cardiovasc Res Inst, Pediat Cardiovasc Res Ctr, Esfahan, Iran
[2] Isfahan Univ Med Sci, Metab Liver Dis Res Ctr, Esfahan, Iran
[3] Iran Univ Med Sci, Trauma & Injury Res Ctr, Tehran, Iran
[4] Isfahan Univ Med Sci, Sch Med, Esfahan, Iran
[5] Isfahan Univ Med Sci, Child Growth & Dev Res Ctr, Esfahan, Iran
关键词
Mucopolysaccharidoses; Children; Heart; Echocardiography; ENZYME-REPLACEMENT THERAPY; INVOLVEMENT; MORTALITY; CHILDREN;
D O I
10.1007/s10554-023-02983-y
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
Purpose Mucopolysaccharidoses (MPS) are a group of rare genetic diseases and heart involvement is one of the important conflicts in most types, which may cause serious complications. We used M-Mode and two-dimensional speckle tracking echocardiography (2D-STE) to explore cardiovascular involvements in MPS patients.Method The present cross-sectional study investigated the frequency of cardiac involvements in MPS patients. Included participants were MPS types I, II, III, IV, and VI who underwent specialized echocardiography exams to assess valvular function, systolic and diastolic function, left ventricular ejection fraction (LVEF), and global longitudinal strain (GLS).Results 35 patients were enrolled in this study. The total mean age of patients was 9.58 +/- 5.11 years and 71.4% were male. Type IV (40%) and type III (31.4%) were the most frequent MPS. Although LVEF did not differ notably among MPS types, GLS was significantly different (p = 0.029). Mitral regurgitation was observed remarkably more in MPS type III (p = 0.001) while mitral stenosis was more common in type III (p = 0.007). There was a significant association between LVEF and GLS (beta= -0.662; p = 0.025) and between LVEF and MPS type (beta = 1.82; p = 0.025) when adjusted for GLS.Conclusion Cardiac complications are very common and are one of the most important causes of death in MPS patients. 2D-STE seems to be superior to M-Mode for detection of early and subclinical cardiac dysfunction in MPS patients.
引用
收藏
页码:73 / 78
页数:6
相关论文
共 50 条
  • [41] Cardiac features and effects of enzyme replacement therapy in Taiwanese patients with Mucopolysaccharidosis IVA
    Hsiang-Yu Lin
    Ming-Ren Chen
    Shan-Miao Lin
    Chung-Lieh Hung
    Dau-Ming Niu
    Chih-Kuang Chuang
    Shuan-Pei Lin
    Orphanet Journal of Rare Diseases, 13
  • [42] Perturbations in cell signaling elicit early cardiac defects in mucopolysaccharidosis type II
    Costa, Roberto
    Urbani, Andrea
    Salvalaio, Marika
    Bellesso, Stefania
    Cieri, Domenico
    Zancan, Ilaria
    Filocamo, Mirella
    Bonaldo, Paolo
    Szabo, Ildiko
    Tomanin, Rosella
    Moro, Enrico
    HUMAN MOLECULAR GENETICS, 2017, 26 (09) : 1643 - 1655
  • [43] Evaluation of aortic elasticity properties in mucopolysaccharidosis patients; effect of enzyme replacement therapy (ERT) on aortic stiffness
    Ertas, Kerem
    Gul, Ozlem
    Bozaci, Ayse Ergul
    Bilgin, Huseyin
    JOURNAL OF PEDIATRIC ENDOCRINOLOGY & METABOLISM, 2024, 37 (08) : 701 - 708
  • [44] Cardiac evaluation of patients with juvenile dermatomyositis
    Akgun, Gokmen
    Sozeri, Betul
    Basar, Evic Zeynep
    Sahin, Nihal
    Bayrak, Yunus Emre
    Ulu, Kadir
    Gungor, Huseyin Salih
    Dogan, Mustafa
    Oner, Taliha
    Karacan, Mehmet
    Babaoglu, Kadir
    Anik, Yonca
    Sonmez, Hafize Emine
    PEDIATRIC RESEARCH, 2025, 97 (01) : 333 - 340
  • [45] Tetralogy of Fallot: cardiac imaging evaluation
    Sanchez Ramirez, Carlos Jerjes
    Perez de Isla, Leopoldo
    ANNALS OF TRANSLATIONAL MEDICINE, 2020, 8 (15)
  • [46] Evaluation of the long-term treatment effects of intravenous idursulfase in patients with mucopolysaccharidosis II (MPS II) using statistical modeling: data from the Hunter Outcome Survey (HOS)
    Muenzer, Joseph
    Botha, Jaco
    Harmatz, Paul
    Giugliani, Roberto
    Kampmann, Christoph
    Burton, Barbara K.
    ORPHANET JOURNAL OF RARE DISEASES, 2021, 16 (01)
  • [47] Preparticipation Cardiac Evaluation Findings in a Cohort of Collegiate Female Athletes
    Rambarat, Cecil A.
    Reifsteck, Fred
    Clugston, James R.
    Handberg, Eileen M.
    Martinez, Matthew W.
    Hamburger, Robert
    Street, Joan M.
    Asken, Breton
    Taha, Yasmeen
    Kelling, Matthew
    Dimza, Michelle
    Dasa, Osama
    Pepine, Carl J.
    Edenfield, Katherine M.
    AMERICAN JOURNAL OF CARDIOLOGY, 2021, 140 : 134 - 139
  • [48] Cardiac magnetic resonance findings and prognosis in type 1 myotonic dystrophy
    Leali, Marco
    Aimo, Alberto
    Ricci, Giulia
    Torri, Francesca
    Todiere, Giancarlo
    Vergaro, Giuseppe
    Grigoratos, Chrysanthos
    Giannoni, Alberto
    Aquaro, Giovanni Donato
    Siciliano, Gabriele
    Emdin, Michele
    Passino, Claudio
    Barison, Andrea
    JOURNAL OF CARDIOVASCULAR MEDICINE, 2023, 24 (06) : 340 - 347
  • [49] Functional capacity evaluation of patients with mucopolysaccharidosis
    Guarany, Nicole Ruas
    Schwartz, Ida Vanessa D.
    Guarany, Fabio Coelho
    Giugliani, Roberto
    JOURNAL OF PEDIATRIC REHABILITATION MEDICINE, 2012, 5 (01) : 37 - 46
  • [50] The Mucopolysaccharidosis
    Bhakthaganesh, Kusumitha
    Manumuraleekrishna
    Vanathi, Murugesan
    Ahmed, Shifa
    Gupta, Noopur
    Tandon, Radhika
    TAIWAN JOURNAL OF OPHTHALMOLOGY, 2023, 13 (04) : 443 - 450